These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2988153)

  • 21. Multiple proteases regulate neurite outgrowth in NB2a/dl neuroblastoma cells.
    Shea TB; Beermann ML; Nixon RA
    J Neurochem; 1991 Mar; 56(3):842-51. PubMed ID: 1993897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of proteolytic activity of calcium activated neutral protease by leupeptin and antipain.
    Toyo-Oka T; Shimizu T; Masaki T
    Biochem Biophys Res Commun; 1978 May; 82(2):484-91. PubMed ID: 666855
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuromuscular recovery using calcium protease inhibition after median nerve repair in primates.
    Badalamente MA; Hurst LC; Stracher A
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5983-7. PubMed ID: 2548194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of a protease inhibitor, leupeptin, on the development of influenza pneumonia, mediated by concomitant bacteria.
    Tashiro M; Klenk HD; Rott R
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():2039-41. PubMed ID: 3298542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the calcium-calpain pathway in cytoskeletal damage after eccentric contractions.
    Zhang BT; Yeung SS; Allen DG; Qin L; Yeung EW
    J Appl Physiol (1985); 2008 Jul; 105(1):352-7. PubMed ID: 18499778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological roles of leupeptin and extracellular proteases in mycelium development of Streptomyces exfoliatus SMF13.
    Kim IS; Lee KJ
    Microbiology (Reading); 1995 Apr; 141 ( Pt 4)():1017-25. PubMed ID: 7773379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of indomethacin and leupeptin on muscle cathepsin B activity and protein degradation during sepsis.
    Hummel RP; Warner BW; James JH; Hasselgren PO; Fischer JE
    J Surg Res; 1988 Jul; 45(1):140-4. PubMed ID: 3392987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of the protease inhibitor leupeptin against myocardial stunning.
    Matsumura Y; Kusuoka H; Inoue M; Hori M; Kamada T
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):135-42. PubMed ID: 7690085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mode of action of bestatin and leupeptin to induce the accumulation of acid soluble peptides in rat liver in vivo and the properties of the accumulated peptides. The important role of bestatin- and leupeptin-sensitive proteases in the protein degradation pathway in vivo.
    Takahashi S; Kato H; Takahashi A; Noguchi T; Naito H
    Int J Biochem; 1987; 19(5):401-12. PubMed ID: 3595989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new protease in hog thyroid lysosomes. I. The presence of a leupeptin-sensitive protease in the soluble fraction of thyroid lysosomes.
    Nakagawa H; Endo Y; Ohtaki S
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):383-9. PubMed ID: 7027711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of protease inhibitors and decreased temperature on the degradation of different classes of proteins in cultured hepatocytes.
    Neff NT; DeMartino GN; Goldberg AL
    J Cell Physiol; 1979 Dec; 101(3):439-57. PubMed ID: 528571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of leupeptin on protein turnover in normal and dystrophic chicken skeletal muscle cells in culture.
    Riebow JF; Young RB
    Biochem Med; 1980 Jun; 23(3):316-23. PubMed ID: 7417239
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence for the role of proteinases in uremic catabolism.
    Schaefer RM; Teschner M; Peter G; Leibold J; Kulzer P; Heidland A
    Adv Exp Med Biol; 1988; 240():323-9. PubMed ID: 3072849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the protease inhibitor leupeptin on proteolytic activities and regeneration of mouse skeletal muscles after exercise injuries.
    Salminen A
    Am J Pathol; 1984 Oct; 117(1):64-70. PubMed ID: 6385726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ca-activated neutral protease and its inhibitors: in vitro effect on intact myofibrils.
    Sugita H; Ishiura S; Suzuki K; Imahori K
    Muscle Nerve; 1980; 3(4):335-9. PubMed ID: 6251364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of protein degradation and atrophy in cultured fetal mouse hearts by leupeptin.
    Libby P; Ingwall JS; Goldberg AL
    Am J Physiol; 1979 Jul; 237(1):E35-9. PubMed ID: 464050
    [No Abstract]   [Full Text] [Related]  

  • 37. Acid proteolytic activities in mouse liver and muscle tissues after treatment with protease inhibitor leupeptin.
    Salminen A; Kihlström M; Vihko V
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 79(1):93-5. PubMed ID: 6149885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle cell membranes from early degeneration muscle cell fibers in Solenopsis are leaky to lanthanum: electron microscopy and X-ray analysis.
    Jones RG; Davis WL
    Anat Rec; 1985 Jun; 212(2):123-8. PubMed ID: 3842035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-dependent and calcium-independent protease activities in skeletal muscle during sepsis.
    Bhattacharyya J; Thompson K; Sayeed MM
    Circ Shock; 1991 Oct; 35(2):117-22. PubMed ID: 1777946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The activation of protein degradation in muscle by Ca2+ or muscle injury does not involve a lysosomal mechanism.
    Furuno K; Goldberg AL
    Biochem J; 1986 Aug; 237(3):859-64. PubMed ID: 3099758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.